Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate for Postherpetic Neuralgia
NCT00492323Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Mar 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Carisbamate Sequence with Placebo Sequence (2 arms). Primary endpoint: Mean of the last 7 average daily PHN scores of the first treatment period at 4 weeks. Started Mar 2007; status: completed.
02
Drugs
carisbamate
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00492323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492323.